Applicant, as named in the Orange Book

Amneal

Amneal Pharmaceuticals Inc · Nasdaq: AMRX

Company and ticker: cliffwatch mapping, checked against SEC EDGAR · SEC filings

Next listed expiry: Ongentys on 12 Dec 2032. 3 products with live protection, 4 without.

Products with listed protection

Drug	Ingredient	Earliest generic entry	Basis
Ongentys NDA 212489 · 2 strengths opicapone	opicapone	12 Dec 2032 patent	patent
Brekiya (Autoinjector) NDA 215400 dihydroergotamine mesylate	dihydroergotamine mesylate	24 Aug 2039 patent	patent
Potassium Phosphates In 0.9% Sodium Chloride NDA 218343 potassium phosphate, dibasic; potassium phosphate, monobasic	potassium phosphate, dibasic; potassium phosphate, monobasic	12 Oct 2041 patent	patent

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.

Products without listed protection (4)

Drug	Ingredient	Earliest generic entry	Basis
Activella NDA 020907 estradiol; norethindrone acetate	estradiol; norethindrone acetate	open now no listed protection	no listed protection
Lioresal NDA 020075 · 3 strengths baclofen	baclofen	open now no listed protection	no listed protection
Sodium Bicarbonate NDA 220790 sodium bicarbonate	sodium bicarbonate	open now no listed protection	no listed protection
Zomig NDA 021450 · 2 strengths zolmitriptan	zolmitriptan	open now no listed protection	no listed protection